Mayara Dumont Cunha
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Mayara Dumont Cunha has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Marcelo Henrique Fernandes Ottoni
Programa de Pós-Graduação em Ciências da Saúde, Universidade Federal dos Vales do Jequitinonha e Mucuri, Diamantina 39100-000, MG, Brazil
1 shared publication - Natália Cristina da Silva
Universidade Federal dos Vales do Jequitinhonha e Mucuri, Brasil
1 shared publication - Rita Carolina Figueiredo Duarte
Department of Clinical and Toxicological Analysis, Faculty of Pharmacy, Laboratory of Hematology Federal University of Minas Gerais Belo Horizonte Brazil
1 shared publication - Samuel Jorge Teixeira Araújo
Department of Nursing Federal University of the Valleys of Jequitinhonha and Mucuri Diamantina Brazil
1 shared publication - Thabata Coaglio Lucas
Universidade Federal dos Vales do Jequitinhonha e Mucuri, Brasil
1 shared publication
Latest Publications
- 27 April 2022
- Published by Wiley in Artificial Organs
- Vol. 46 (9) , 1866-1875
Hemostatic changes in patients undergoing hemodialysis: Differences between central venous catheters and arterio‐venous fistulas
Background: Failure to mature the fistula in patients undergoing hemodialysis leads to prolonged use of the central venous catheter (CVC) and can compromise the patency of the catheter and the arteriovenous fistula (AVF) due to thrombus development. Objective: To evaluate hemostatic changes in patients undergoing hemodialysis with prolonged use of CVC or AVF. Method: Cross‐sectional study with a total of 200 adult participants who were divided into the following groups: I:control; II: patients who had 5–8 months of CVC insertion; III: patients who had 9–36 months of insertion; IV patients who had 5–8 months of AVF; and V: patients who had 9–36 months of AVF. Platelet activation was investigated by expressions of GPIIb/IIIa and p‐selectin using flow cytometry. The Elisa‐thrombomodulin (TM) test was used to compare groups III and V. Results: The p‐selectin percentage expression of group I was 15.30 (12.30–16.80), II 23.25 (20.75–30.55); and III 54.00 (44.75–59.29) were significant ( p < 0.001). Groups I, IV, and V were also significant ( p < 0.001). The median fluorescence for GPIIb/IIIa for groups I, II, and III were significant ( p < 0.0001). As for the Elisa test, an increased absorbance of TM was verified in patients who used the CVC 4372 (3951–4733) compared with those patients who used the AVF 2162 (1932–2485) ( p < 0.0001). Conclusion: It can be concluded that CVC patients had a larger platelet expression of GPIIb/IIIa and p‐selectin than AVF patients. The high concentration of TM in CVC patients may suggest a greater stimulation of the intrinsic than extrinsic coagulation pathways.
- 27 April 2022
- Published by Wiley in Artificial Organs
- Vol. 46 (9) , 1866-1875
Hemostatic changes in patients undergoing hemodialysis: Differences between central venous catheters and arterio‐venous fistulas
Background: Failure to mature the fistula in patients undergoing hemodialysis leads to prolonged use of the central venous catheter (CVC) and can compromise the patency of the catheter and the arteriovenous fistula (AVF) due to thrombus development. Objective: To evaluate hemostatic changes in patients undergoing hemodialysis with prolonged use of CVC or AVF. Method: Cross‐sectional study with a total of 200 adult participants who were divided into the following groups: I:control; II: patients who had 5–8 months of CVC insertion; III: patients who had 9–36 months of insertion; IV patients who had 5–8 months of AVF; and V: patients who had 9–36 months of AVF. Platelet activation was investigated by expressions of GPIIb/IIIa and p‐selectin using flow cytometry. The Elisa‐thrombomodulin (TM) test was used to compare groups III and V. Results: The p‐selectin percentage expression of group I was 15.30 (12.30–16.80), II 23.25 (20.75–30.55); and III 54.00 (44.75–59.29) were significant ( p < 0.001). Groups I, IV, and V were also significant ( p < 0.001). The median fluorescence for GPIIb/IIIa for groups I, II, and III were significant ( p < 0.0001). As for the Elisa test, an increased absorbance of TM was verified in patients who used the CVC 4372 (3951–4733) compared with those patients who used the AVF 2162 (1932–2485) ( p < 0.0001). Conclusion: It can be concluded that CVC patients had a larger platelet expression of GPIIb/IIIa and p‐selectin than AVF patients. The high concentration of TM in CVC patients may suggest a greater stimulation of the intrinsic than extrinsic coagulation pathways.